ARCHIVES

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

This article is from The Cancer Letter archive.

Vol. 37 No. 33 | September 9, 2011

Download PDF Visit The Full Archive

Related Articles

In Congress: Clinton Backs Genetic Privacy Bills, But Plans Changes Proposals

July 18, 1997

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

DCPC Board OKS P01 Grants Program In Nutrition Research

March 11, 1994

Letter: ORI And Plotkin Should Release Report

June 23, 1995

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979